Open-Label Study of a Proprietary Treatment Program Targeting Type A γ-Aminobutyric Acid Receptor Dysregulation in Methamphetamine Dependence

OBJECTIVE To evaluate the safety and efficacy of the pharmacological component of a proprietary medical treatment program targeting type A γ-aminobutyric acid receptor dysregulation in adults who met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision criteria fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Mayo Clinic proceedings 2007-10, Vol.82 (10), p.1170-1178
Hauptverfasser:	Urschel, Harold C., MD, MMA, Hanselka, Larry L., PhD, Gromov, Irina, MD, PhD, White, Lenae, MD, Baron, Michael, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Amines - administration & dosage Amphetamine abuse Biological and medical sciences Care and treatment Cyclohexanecarboxylic Acids - administration & dosage Drug abuse Female Flumazenil - administration & dosage Gabapentin gamma-Aminobutyric Acid - administration & dosage General aspects Humans Hydroxyzine - administration & dosage Internal Medicine Male Medical sciences Methamphetamine Middle Aged Neuropharmacology Patient Dropouts Pharmacology. Drug treatments Prospective Studies Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Receptors, GABA - drug effects Receptors, GABA - physiology Substance-Related Disorders - drug therapy Substance-Related Disorders - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!